Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Alfasigma gains arthritis drug, access to new markets with M&A play
In a deal announced this week, Alfasigma spent an undisclosed sum to continue its global expansion in immunology. | Alfasigma will add key drugs like Nordimet through the deal, as well as Nordic Pharma’s women’s health, critical care and ophthalmology portfolios.
TL;DRAI
Alfasigma acquires Nordic Pharma, adding rheumatology portfolio (Nordimet methotrexate) with Japan, Canada market access. Follows M&A-focused playbook: external expansion in rare disease and immunology builds global specialty presence through targeted consolidation.
501 words~2 min read
